Proteomic comparison of osteoarthritic and reference human menisci using data-independent acquisition mass spectrometry.


Journal

Osteoarthritis and cartilage
ISSN: 1522-9653
Titre abrégé: Osteoarthritis Cartilage
Pays: England
ID NLM: 9305697

Informations de publication

Date de publication:
08 2020
Historique:
received: 30 01 2020
revised: 09 04 2020
accepted: 01 05 2020
pubmed: 15 5 2020
medline: 27 7 2021
entrez: 15 5 2020
Statut: ppublish

Résumé

Recent research in knee osteoarthritis (OA) highlights the role of the meniscus in OA pathology. Our aim was to compare the proteomes of medial and lateral menisci from end-stage medial compartment knee OA patients, with reference menisci from knee-healthy deceased donors, using mass spectrometry. Tissue plugs of Ø3 mm were obtained from the posterior horns of the lateral and medial menisci from one knee of 10 knee-healthy deceased donors and 10 patients undergoing knee replacement. Proteins were extracted and prepared for mass spectrometric analysis. Statistical analysis was conducted on abundance data that was log We identified a total of 835 proteins in all samples, of which 331 were included in the statistical analysis. The largest differences could be seen between the medial menisci from OA patients and references, with most proteins showing higher intensities in the medial menisci from OA patients. Several matrix proteins, e.g., matrix metalloproteinase 3 (MMP3) (4.3 times higher values [95%CI 1.8, 10.6]), TIMP1 (3.5 [1.4, 8.5]), asporin (4.1 [1.7, 10.0]) and versican (4.4 [1.8, 10.9]), all showed higher abundance in medial menisci from OA patients compared to medial reference menisci. OA medial menisci also showed increased activation of several pathways involved in inflammation. An increase in protein abundance for proteins such as MMP and TIMP1 in the medial menisci from OA patients suggests simultaneous activation of both catabolic and anabolic processes that warrants further attention.

Identifiants

pubmed: 32407894
pii: S1063-4584(20)30994-8
doi: 10.1016/j.joca.2020.05.001
pmc: PMC7397514
pii:
doi:

Substances chimiques

ASPN protein, human 0
Extracellular Matrix Proteins 0
TIMP1 protein, human 0
Tissue Inhibitor of Metalloproteinase-1 0
VCAN protein, human 0
Versicans 126968-45-4
MMP3 protein, human EC 3.4.24.17
Matrix Metalloproteinase 3 EC 3.4.24.17

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1092-1101

Subventions

Organisme : European Research Council
ID : 771121
Pays : International

Informations de copyright

Copyright © 2020 The Authors. Published by Elsevier Ltd.. All rights reserved.

Références

Arthritis Rheum. 2009 Mar;60(3):831-9
pubmed: 19248082
Osteoarthritis Cartilage. 2016 Feb;24(2):270-3
pubmed: 26318660
Cytokines Cell Mol Ther. 2000 Jun;6(2):71-9
pubmed: 11108572
Matrix Biol. 2017 Nov;63:11-22
pubmed: 27988350
Nat Biotechnol. 2010 Apr;28(4):337-40
pubmed: 20379180
Biotechnol Adv. 2018 Nov 1;36(6):1657-1698
pubmed: 29548878
Arthritis Res Ther. 2013 Nov 06;15(6):R180
pubmed: 24286485
Radiology. 2016 Jan;278(1):164-71
pubmed: 26172533
Mol Cell Proteomics. 2005 Oct;4(10):1487-502
pubmed: 15979981
Nat Protoc. 2017 Jul;12(7):1289-1294
pubmed: 28569762
Ther Adv Musculoskelet Dis. 2013 Apr;5(2):77-94
pubmed: 23641259
Arthritis Rheum. 1983 Jan;26(1):69-76
pubmed: 6401994
Biomarkers. 2016 Nov;21(7):639-44
pubmed: 27122451
Mol Cell Proteomics. 2006 Jan;5(1):144-56
pubmed: 16219938
Ann Rheum Dis. 1984 Aug;43(4):635-40
pubmed: 6548109
Arthritis Res Ther. 2012 Jan 08;14(1):R7
pubmed: 22225630
Osteoarthritis Cartilage. 2014 Jul;22(7):996-1006
pubmed: 24852699
BMC Musculoskelet Disord. 2018 Nov 29;19(1):416
pubmed: 30497455
Osteoarthritis Cartilage. 2019 Mar;27(3):476-483
pubmed: 30552967
Curr Opin Rheumatol. 2018 Jan;30(1):114-120
pubmed: 29035928
Connect Tissue Res. 2017 May - Jul;58(3-4):225-237
pubmed: 27715381
J Mol Med (Berl). 2017 Apr;95(4):431-444
pubmed: 28070626
Osteoarthritis Cartilage. 2009 Jul;17(7):832-42
pubmed: 19217805
Genes Dev. 1995 May 1;9(9):1033-45
pubmed: 7744246
J Knee Surg. 2016 Jan;29(1):47-62
pubmed: 25338297
Am J Sports Med. 1982 Mar-Apr;10(2):90-5
pubmed: 7081532
Clin Anat. 2015 Mar;28(2):269-87
pubmed: 25125315
Connect Tissue Res. 2017 May - Jul;58(3-4):282-294
pubmed: 28121190
Curr Opin Rheumatol. 2019 Jan;31(1):70-79
pubmed: 30394938
J Bone Joint Surg Br. 1961 Nov;43-B:752-7
pubmed: 14038135
Osteoarthritis Cartilage. 2019 Dec;27(12):1790-1799
pubmed: 31301431

Auteurs

E Folkesson (E)

Lund University, Faculty of Medicine, Department of Clinical Sciences Lund, Orthopaedics, Clinical Epidemiology Unit, Lund, Sweden; Lund University, Faculty of Medicine, Department of Clinical Sciences Lund, Rheumatology and Molecular Skeletal Biology, Lund, Sweden. Electronic address: elin.folkesson@med.lu.se.

A Turkiewicz (A)

Lund University, Faculty of Medicine, Department of Clinical Sciences Lund, Orthopaedics, Clinical Epidemiology Unit, Lund, Sweden.

N Ali (N)

Lund University, Faculty of Medicine, Department of Clinical Sciences Lund, Orthopaedics, Clinical Epidemiology Unit, Lund, Sweden.

M Rydén (M)

Lund University, Faculty of Medicine, Department of Clinical Sciences Lund, Orthopaedics, Clinical Epidemiology Unit, Lund, Sweden.

H V Hughes (HV)

Lund University, Faculty of Medicine, Department of Clinical Sciences Lund, Orthopaedics, Clinical Epidemiology Unit, Lund, Sweden.

J Tjörnstrand (J)

Lund University, Faculty of Medicine, Department of Clinical Sciences Lund, Orthopaedics, Clinical Epidemiology Unit, Lund, Sweden; Department of Orthopaedics, Skåne University Hospital, Lund, Sweden.

P Önnerfjord (P)

Lund University, Faculty of Medicine, Department of Clinical Sciences Lund, Rheumatology and Molecular Skeletal Biology, Lund, Sweden.

M Englund (M)

Lund University, Faculty of Medicine, Department of Clinical Sciences Lund, Orthopaedics, Clinical Epidemiology Unit, Lund, Sweden; Clinical Epidemiology Research and Training Unit, Boston University School of Medicine, Boston, MA, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH